HIV AIDS

>

Latest News

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Real-World Use of Cabotegravir for HIV PrEP

October 25th 2023

Your daily dose of the clinical news you may have missed.

IDWeek 2023: New Data Provides Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP / Image credit: ©Chris Bjornberg/AdobeStock
IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP

October 15th 2023

Image credit HIV  ©Chris Bjornberg/Shutterstock.com
In People Living with HIV, Switch from Oral ART to Long-Acting Injectable Significantly Improved Adherence, Persistence

October 11th 2023

©ktsdesign/Shutterstock.com
Real-World Study Finds Long-Acting Cabotegravir+Rilpivirine Highly Effective in Persons with HIV with Detectable Viral Loads at Treatment Inititiaton

October 11th 2023

USPSTF Publishes Final Recommendation Statement on HIV PrEP  image credit prep pill ©magann/stock.adobe.com
USPSTF Publishes Final Recommendation Statement on HIV PrEP

August 23rd 2023

More News

© 2024 MJH Life Sciences

All rights reserved.